CBUS Cibus US LLC
NEUTRAL
Impact: 2/10
PRESS-RELEASE
Press release: contract
Latest settled — T+20d
CBUS ▼ -1.34% at T+20d
NEUTRAL call ✗ call lost -1.34% · α vs SPY -6.99% · entry $1.49 → $1.47
Currently $1.23 · -17.45% from $1.49 entry
T+1d
+3.36%
call +3.36% · α +2.56%
$1.54
settled 5w ago
T+5d
-7.38%
call -7.38% · α -10.32%
$1.38
settled 4w ago
T+20d
-1.34%
call -1.34% · α -6.99%
$1.47
settled 8d ago
T+60d
—
call — · α —
—
in 7w
Price Chart
Loading chart...
Executive Summary
Cibus announced transfer of gene-edited herbicide-tolerant rice materials to partner Interoc for testing and production in Latin America. This is a non-financial pipeline progress milestone with no disclosed commercial terms or near-term revenue impact.
Actionable Insight
Monitor for definitive agreement and commercial launch timeline. No near-term catalyst; partnership progress is incremental and non-material without revenue terms.
Key Facts
- Cibus transferred gene-edited rice materials to Interoc for herbicide tolerance trait.
- Interoc to begin testing and production for Latin American commercial launch.
- No definitive licensing agreement or financial terms disclosed.
- Milestone achieved on schedule; additional trait materials expected over next year.
Financial Impact
No financial figures disclosed; potential future royalties not quantified.
Risk Factors
- Cibus needs additional near-term funding to finance activities; capital markets risk.
- No definitive license agreement yet; negotiations may fail.
- Regulatory frameworks for gene editing may change, impacting commercialization.
Market Snapshot
Exchange
Nasdaq
Sector
Agricultural Chemicals
Analyst Consensus
78% bullish (9 analysts)
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3286548 |
10 reports for CBUS
100%
Hit rate
best @ T+20▲ +48.38%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 9, 2026
today
|
8-K
| $1.35 awaiting T+5 | awaiting T+5 | — | $1.23 (−8.89%) |
|
Jun 8, 2026
1d ago
|
Press Release
| $1.22 awaiting T+5 | awaiting T+5 | — | $1.23 (+1.23%) |
|
May 26, 2026
14d ago
|
EFFECT
| $1.43 $1.39 | ▲ +2.80% | ▲ +4.01% | $1.23 (+13.99%) |
|
May 14, 2026
26d ago
|
8-K
| $1.31 $1.38 | ▲ +5.34% | ▲ +4.38% | $1.23 (−6.11%) |
|
May 4, 2026
5w ago
|
Press Release
| $1.49 $1.38 | ▼ −7.38% | ▼ −10.32% | $1.23 (−17.45%) |
|
Apr 20, 2026
7w ago
|
DEFA14A
| $1.49 $1.42 | ▼ −4.70% | ▼ −5.78% | $1.23 (−17.45%) |
|
Mar 26, 2026
10w ago
|
424B5
| $1.88 $1.91 | ▼ −1.60% | ▲ +2.27% | $1.23 (+34.57%) |
|
Mar 26, 2026
10w ago
|
Press Release
| $2.13 $1.98 | ▼ −7.04% | ▼ −8.68% | $1.23 (−42.25%) |
|
Mar 25, 2026
10w ago
|
Press Release
| $2.13 $1.98 | ▼ −7.04% | ▼ −8.68% | $1.23 (−42.25%) |
|
Mar 17, 2026
12w ago
|
Press Release
| $2.77 $2.87 | ▼ −3.61% | ▼ −4.33% | $1.23 (+55.60%) |
Showing 10 of 10
US Market Status
Market Closed — Opens Thu (9h 49m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access